Welcome to Coaginfo.com, The
Coagulation Information Source, an Internet site designed
for physicians and other health care personnel who want information
about topics related to the pathophysiology, pharmacology,
and clinical aspects of hemostasis, including therapeutic,
pharmacologic, and monitoring approaches to managing coagulation
Clinical applications of
hemostatic agents are rapidly growing in clinical medicine.
Because of the pivotal role of thrombosis in cardiovascular
medicine, neurology, critical care, surgery, perioperative
medicine, and oncology, therapeutic approaches to preventing
both arterial and venous thrombosis are a cornerstone of therapy
in this millennium. Newer heparins (eg, low molecular weight
heparin), novel antithrombotic agents (eg, recombinant hirudin),
the glycoprotein IIb/IIIa receptor antagonists, and clopidogrel
(Plavix) have assumed a pivotal role in cardiology and clinical
medicine. Many of these agents also pose a challenge to the
physicians, and other health care personnel involved in their
management due to the paradox between the need to prevent
thrombosis in these patients and the need for therapeutic
hemostasis at surgical sites or other sites of vascular injury.
Biological agents (eg, antithrombin III and activated protein
C) are also being evaluated in clinical trials and offer novel
therapeutic applications of physiologic proteins. This site
will explore important issues in managing these patients and
understanding their applications.
This site is sponsored by
DocMD.com, an Internet
site dedicated to bringing useful information to physicians
and other healthcare personnel. Be sure to visit DocMD.com
to keep up on what is new and interesting in healthcare, and
for other helpful information. Please contact us at Info@DocMD.com
if you have additional suggestions or comments.